









Markets
/
Stocks
/
nasdaq-telo
/

Telomir Pharmaceuticals Inc

TELO

1.410USD

+0.040+2.92%

Close 12/19, 16:00（ET）Quotes delayed by 15 min

47.70MMarket Cap

LossP/E TTM



Telomir Pharmaceuticals Inc

1.410

+0.040+2.92%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

You can check out the annual or quarterly balance sheets of Telomir Pharmaceuticals Inc here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

Total equity

Cash, cash equivalents and short-term investments

778.14%7.33M

-59.96%754.32K

-87.69%403.00K

102753.86%1.27M

33939.07%834.64K

12777.91%1.88M

--3.27M

--1.23K

--2.45K

--14.63K

- Cash and cash equivalents

778.14%7.33M

-59.96%754.32K

-87.69%403.00K

102753.86%1.27M

33939.07%834.64K

12777.91%1.88M

--3.27M

--1.23K

--2.45K

--14.63K

Receivables

----

0.00%130.00K

--130.00K

----

-Other receivables

----

0.00%130.00K

--130.00K

----

Prepaid expenses

-5.85%72.82K

-14.26%75.29K

-10.75%88.19K

8016.97%57.87K

7931.88%77.35K

--87.81K

--98.81K

--713.00

--963.00

----

Other current assets

--0.00

----

--0.00

----

--0.00

--303.28K

--102.89K

--81.44K

Total current assets

610.39%7.40M

-60.53%829.61K

-85.98%491.19K

204.21%1.32M

340.94%1.04M

2087.79%2.10M

--3.50M

--435.23K

--236.31K

--96.07K

Non-current assets

Other non-current assets

----

-100.00%0.00

--0.00

--4.34M

--5.08M

--5.83M

Total non-current assets

----

-100.00%0.00

--0.00

--4.34M

--5.08M

--5.83M

Total assets

610.39%7.40M

-60.53%829.61K

-85.98%491.19K

-72.26%1.32M

-80.41%1.04M

-64.51%2.10M

--3.50M

--4.77M

--5.32M

--5.92M

Liabilities

Current liabilities

-Other payables

0.00%93.43K

-33.43%93.43K

-63.73%93.43K

-82.28%93.43K

-92.85%93.43K

22572.21%140.34K

--257.63K

--527.38K

--1.31M

--619.00

Accrued expenses

----

--7.36K

----

Short-term debt and lease liabilities

----

-100.00%0.00

--0.00

--101.00K

--1.34M

--487.91K

-Short-term debt

----

-100.00%0.00

--0.00

--101.00K

--1.34M

--487.91K

Other current liabilities

0.00%93.43K

-33.43%93.43K

-63.73%93.43K

-82.28%93.43K

-92.85%93.43K

22572.21%140.34K

--257.63K

--527.38K

--1.31M

--619.00

Total current liabilities

-29.52%422.81K

-34.78%348.39K

34.06%652.29K

-49.01%680.97K

-80.90%599.91K

-73.72%534.15K

--486.55K

--1.34M

--3.14M

--2.03M

Non-current liabilities

Long-term debt and lease liabilities

--0.00

Other non-current liabilities

--0.00

----

--0.00

----

Total liabilities

-29.52%422.81K

-34.78%348.39K

34.06%652.29K

-49.01%680.97K

-80.90%599.91K

-73.72%534.15K

--486.55K

--1.34M

--3.14M

--2.03M

Shareholders' equity

Common equity

63.21%45.93M

64.25%38.33M

39.77%32.62M

78.49%31.24M

306.95%28.14M

237.46%23.34M

--23.34M

--17.50M

--6.92M

Retained earnings

-40.62%-38.95M

-73.87%-37.85M

-61.31%-32.78M

-117.55%-30.60M

-484.74%-27.70M

-619.45%-21.77M

---20.32M

---14.06M

---4.74M

---3.03M

Capital reserves

63.21%45.93M

64.25%38.33M

39.77%32.62M

78.49%31.24M

306.95%28.14M

237.46%23.34M

--23.34M

--17.50M

--6.92M

Total equity

1478.77%6.98M

-69.30%481.22K

-105.34%-161.11K

-81.30%643.04K

-79.70%442.07K

-59.70%1.57M

--3.02M

--3.44M

--2.18M

--3.89M

Currency unit

USD

Audit opinions

FAQs

What is the balance sheet?



It is a financial report that summarises the assets, liabilities, and shareholders’ equity of a company at a specific point in time.

KeyAI

